Market Overview

Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc

Share:
Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc
Related GILD
Gilead's Yescarta Cancer Treatment Approved, Some Analysts Shrug
Gilead Volatile After Kite Pharma's Yescarta Gets FDA Approval
These 5 Top Stocks Are Moving Late On News: S&P 500 Futures (Investor's Business Daily)
Related C
Big Bank Q3 Earnings Roundup
Citigroup, GM, Freeport-McMoRan, Las Vegas Sands: Fast Money Picks For October 17
The Vetr community has downgraded $C to 2.5-Stars (Vetr)

On CNBC's Mad Money, Jim Cramer said that Gilead Sciences, Inc. (NASDAQ: GILD) has to do an acquisition. Without it, the stock is not going to move higher, because the company has a lot of cash and not a lot of growth.

Cramer thinks Citigroup Inc (NYSE: C) was well prepared for the stress test, and he believes it is a buy at its current price.

Posted-In: Jim CramerBiotech CNBC Long Ideas Jim Cramer Media Trading Ideas General

 

Related Articles (GILD + C)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...